The OCMX™ is pleased to announce the listing of Elminda Limited to its online portal which offers Investors and Advisors the ability to participate in this opportunity.

HERZLIYA, ISRAEL, November 28, 2018 /24-7PressRelease/ — Headquarters and R&D in Israel, US subsidiary. Elminda is a unique neuro-technology company harnessing data science and Artificial Intelligence to change the way we diagnose and treat brain disease. A world-class multi-disciplinary team of scientists, physicians, engineers and business entrepreneurs. Wide IP coverage and the world’s largest database of brain function information. Deployed in over 25 sites in the US, Israel and Europe and initial partnerships in China, with applications ranging from detection of early signs of memory problems, assessment of depression, as well as a quick evaluation of the effectiveness of various therapies on the brain. Started to ramp up revenues and are establishing strategic partnerships for distribution.

The OCMX™ is pleased to announce the listing of Elminda Limited to its online portal which offers Investors and Advisors the ability to participate in this opportunity.

The OCMX™ has spent considerable time completing its due diligence on Elminda Limited and concluded that there is indeed a tremendous opportunity for Investors and Advisors.

The OCMX™ noted that Elminda Limited exhibits the main components of any solid investment opportunity, namely a solid management team, a great track record, and a number of key competitive advantages.


Dr. Arun Menawat, Chairman of the Board
An accomplished history of executive leadership success in the healthcare industry leading companies from start‐up to fast growth success. Dr. Menawat served as the President, CEO and Chairman of Novadaq Technologies Inc., leading the company from start‐up, to successful IPO, to leading developer and provider of clinically relevant imaging solutions for use in surgical and diagnostic procedures.

Served as President at Cedara Software, which was sold to Merge Healthcare and ultimately to IBM for their Watson program. Ph.D. in Chemical (Bio) Engineering from the University of Maryland, while concurrently completing a fellowship in biomedical engineering at the NIH, Executive MBA from Kellogg School of Management. In 2014, Dr. Menawat was named the EY Ontario Entrepreneur of the Year in the health sciences category.

Mr. Ronen Gadot, CEO
The first investor in elminda, recognizing the significant unmet need in the diagnostics and treatment of brain related disorders. Entrepreneurial leader of creative solutions that are making a difference, he was selected by the World Economic Forum to serve on the council for the future of neurotechnologies and brain sciences.

Previously held several positions at Silicon Valley based Applied Materials, co‐founded Philips’ Global Corporate Venture arm, making Philips one of the most active corporate investors in Israel, and CEO of the European subsidiary of one of Philips portfolio companies, SHL Telemedicine. Former F‐16 pilot and member of the IAF Aerobatic Team, holds a BSc in Industrial Engineering and an MBA from INSEAD.

Prof. Amir Geva, CTO
Founded elminda in 2006 following over 30 years of brain related research conducted as part of his academic and entrepreneurial career. Prof. and head of the Biomedical Laboratory of the Electrical, & Computer Engineering department at the Ben Gurion University and a visiting Prof. at the Technion Institute of Technology. Experienced entrepreneur and founder of companies with a significant managerial track record. Accomplished scientist, with years of brain and EEG research and experience initiated at the research unit of the Israeli Navy.

A worldwide expert in biomedical signal processing and pattern recognition and pioneer in the use of Artificial Intelligence in healthcare with dozens of academic publications in scientific journals and books. Holds a B.Sc, M.Sc and D.Sc. in Electrical and Computer Engineering and Biomedical engineering from the Technion Institute of Technology.

Mr. Geri Katz, CFO
Vast experience as a CFO of private and publicly traded companies, including PowerDsine, (Nasdaq: PDSN) as well as prior COO and CEO of private companies. Experience includes a successful IPO and M&A. BA in Economics and Accounting, CPA.

Dr. Roni Sharon, Medical Director
Board‐Certified Neurologist in the United States and Israel, and currently Director of Headache and Facial pain at Sheba Medical Center. He completed a fellowship at Harvard Medical School’s Brigham and Women’s Hospital in Boston, MA following a residency in Neurology at Mount Sinai Beth Israel in New York, NY. He has years of clinical experience, with many academic publications, and lectures internationally on the subjects of neurology, brain health and wellness.

Dr. Ziv Peremen, VP Medical & Pharma Solutions
An experienced leader with a diverse background in physics, cognitive neuroscience and business development. A lecturer at Tel Aviv University. Holds a BSc in Physics and Philosophy and a PhD in Cognitive Neuroscience from Tel Aviv University.

Mrs. Tanya Damm Bokobza, VP Wellness Solutions
An award winning Industrial Designer & experienced entrepreneur. Previously served as the CEO of a B2B2C, 3D printing pioneering platform as a Google sponsored Entrepreneur. Holds a BFA with honors in Industrial design from RISD and MA Innovation Studies from The academy of art Bezalel.

Mrs. Chen Golan, VP HR & Operations
A hands‐on logistics professional with a multi‐tasking skill set which includes planning, directing, producing and coordinating activities and operations. Specializes in mass media communications.


The OCMX™ is literally changing how companies and investment funds generate exposure in the marketplace and raise funds as we know it. The OCMX™ serves both public and private companies along with investment and mutual funds which need to raise additional funds or gain significant market exposure. It does this by way of connecting the relevant companies, funds, investors, and advisors all in one online transparent portal. The OCMX™ (P2P Financial Inc.) launched in September of 2009 out of Toronto but has since expanded its operations to include Quebec, Alberta, Manitoba, and British Columbia.

The OCMX™ connects investors and advisors directly with companies and investment funds seeking to raise funds or gain broad market exposure. The OCMX™ provides an open venue for innovative growth companies and leading investment funds to generate market awareness, raise funds, or connect with investors and advisors. The OCMX™ provides companies, funds, investors, and advisors instant access to its Online Portal so that they can actively source and connect with their next opportunity, advisor, investor, client, or financing partner.

Contact Us
TD Canada Trust Tower
161 Bay Street, 45th Floor
Toronto, Ontario, M5J 2S1
Tel: 1-866-209-6862
Email: [email protected]

For the original version of this press release, please visit here